N17350
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for N17350, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]